SCHEMBL17484145

SCHEMBL17484145

COC(=O)c1cccc(N2CCc3c(cnc4ccsc34)C2)c1

nearest known ligand 0.70

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KDR P35968 18/20 0.70
PDGFRB P09619 13/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17484161 0.88 KDR (0.67) KDRPDGFRB
SCHEMBL17484155 0.83 KDR (0.69) KDRPDGFRB
SCHEMBL17484159 0.83 KDR (1.00) KDRPDGFRB
SCHEMBL17590015 0.82 KDR (0.57) KDRPDGFRB
SCHEMBL15248099 0.75 KDR (0.58) KDRPDGFRB
SCHEMBL30109408 0.74 ALDH1A1 (0.54) KDRPDGFRB
SCHEMBL19846157 0.74 KDR (0.72) KDRPDGFRB
SCHEMBL18886195 0.73 KDR (0.66) KDRPDGFRB
SCHEMBL1490676 0.72 PLOD2 (0.60)
SCHEMBL15238385 0.72 KDR (0.69) KDRPDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9255096-B1 Substituted 1,2,3,4-tetrahydrobenzo[C][2,7] naphthyridines and derivatives thereof as kinase inhibitors ALLERGAN, INC. (US) 2016-02-09 US claimed
US-9255096-B1 Substituted 1,2,3,4-tetrahydrobenzo[C][2,7] naphthyridines and derivatives thereof as kinase inhibitors ALLERGAN, INC. (US) 2016-02-09 US disclosed
US-9255096-B1 Substituted 1,2,3,4-tetrahydrobenzo[C][2,7] naphthyridines and derivatives thereof as kinase inhibitors ALLERGAN, INC. (US) 2016-02-09 US disclosed